INIS
angiogenesis
100%
carcinomas
100%
chemotherapy
11%
clinical trials
11%
concentration
11%
diseases
11%
doses
11%
drugs
11%
fatigue
11%
immunotherapy
11%
kidneys
100%
levels
11%
losses
11%
metastases
100%
organs
11%
patients
100%
populations
11%
schedules
11%
therapy
55%
tnp
100%
toxicity
22%
tumors
11%
Medicine and Dentistry
Angiogenesis Inhibitor
100%
Antiangiogenic Therapy
12%
Asthenia
12%
Chemotherapeutic Agent
12%
Clear Cell Renal Cell Carcinoma
12%
Combination Therapy
50%
Disease Exacerbation
12%
Dizziness
12%
Drug
12%
Fatigue
12%
Fumagillol Chloroacetylcarbamate
12%
Immunotherapy
12%
Inpatient
12%
Kidney Carcinoma
100%
Kidney Metastasis
37%
Organ
12%
Patient
100%
Picric Acid
100%
Sense
12%
Toxicity
25%
Tumor Regression
12%
Vertigo
12%
Pharmacology, Toxicology and Pharmaceutical Science
Angiogenesis Inhibitor
100%
Asthenia
20%
Chemotherapy
20%
Clinical Trial
20%
Disease Exacerbation
20%
Dizziness
20%
Drug
20%
Fatigue
20%
Immunotherapy
20%
Kidney Carcinoma
100%
Kidney Metastasis
60%
Picric Acid
100%
Renal Cell Carcinoma
20%
Toxicity
40%
Tumor Regression
20%
Vertigo
20%